 "ITC open to acquisition of GSK's Horlicks at right price when up for sale")
Diversified conglomerate ITC Ltd on Friday said it is open to acquisition of GlaxoSmithKline's (GSK) Horlicks brand when it is put up for sale, provided the price is "right".
"We would explore buying the Horlicks brand if it is up for sale and at a right price," managing director of ITC Sanjiv Puri told reporters here on Friday.
According to reports, ITC is in the list of suitors for the popular malt-based health drink brand Horlicks. Nestle, Dabur, Mondalez, Kraft Heinz and Hindustan Unilever were the others also believed to be in the fray.
GSK had gone for a strategic review of the Horlicks brand to fund the Novartis deal pegged at $13 billion.
You’ve hit your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Access to Exclusive Premium Stories Online
Over 30 behind the paywall stories daily, handpicked by our editors for subscribers
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app